| (Values in U.S. Thousands) | Jul, 2025 | Apr, 2025 | Jan, 2025 | Oct, 2024 | Jul, 2024 |
| Sales | 117,260 | 115,940 | 109,680 | 106,800 | 102,120 |
| Sales Growth | +1.14% | +5.71% | +2.70% | +4.58% | +0.89% |
| Net Income | 650 | -3,910 | -6,390 | -14,400 | -18,010 |
| Net Income Growth | +116.62% | +38.81% | +55.63% | +20.04% | +8.67% |
Phreesia Inc (PHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Fiscal Year End Date: 01/31